Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811.SS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE100002YC7

Price
6.77 CNY
Market cap
3.10 bn CNY
P/E (2025)
15.90
P/S (2025)
3.82
Dividend yield
4.43 %
Net margin
24.02 %
Return on equity (ROE)
14.03 %
Return on assets (ROA)
11.46 %

Zhejiang Cheng Yi Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue714.37 m CNY812.35 m CNY
Gross profit489.20 m CNY567.01 m CNY
Operating income221.21 m CNY185.55 m CNY
EBIT229.29 m CNY227.67 m CNY
Net income200.70 m CNY195.12 m CNY
Diluted EPS – continuing operations0.61 CNY0.43 CNY

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Zhejiang Cheng Yi Pharmaceutical Co Ltd

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of formulations and active pharmaceutical ingredients in China and internationally. The company offers glucosamine hydrochloride raw materials and preparations, gastrodin raw materials, ribavirin preparations raw materials, and sulfur dioxide raw materials. It also provides injections, food, capsules, tablets, traditional Chinese medicines, preparations, and intermediates; and joint-related drugs, diuretics and antihypertensive drugs, antiviral drugs, antitumor drugs, vitamins, and sedative and brain-boosting drugs, as well as other health products and medical instruments. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.